Innovative Cancer Immunotherapy with MAGE-A3 mRNA Cancer Vaccines
Open Access
Abstract
Cancer causes over 10 million deaths annually worldwide and remains a significant global health challenge. This study investigated advanced immunotherapy strategies, focusing on mRNA vaccines that target tumor-specific antigens to activate the immune system. We developed a novel mRNA vaccine using O,O′-dimyristyl-N-lysyl aspartate (DMKD) to improve stability and phosphatidylserine (PS) to enhance antigen presentation to immune cells. This vaccine, containing melanoma-associated antigen A3 (MAGE-A3) mRNA encapsulated within lipid nanoparticles (LNPs), was evaluated for its therapeutic potential against colorectal cancer. Our findings demonstrated that MAGE-A3 mRNA-containing DMKD-PS LNPs significantly reduced tumor size and weight, effectively combating metastatic cancer. The vaccine elicited a robust immune response, increasing specific immunoglobulin and cytokine levels without causing histotoxicity in major organs. These results confirm that the DMKD-PS-based MAGE-A3 mRNA vaccine holds promise for cancer prevention and treatment.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1F1A1069625, 2016R1D1A1B03935847)
This publication has 27 references indexed in Scilit:
- The cellular and molecular basis of CD69 function in anti-tumor immunityInternational Immunology, 2022
- Cancer vaccines as promising immuno-therapeutics: platforms and current progressJournal of Hematology & Oncology, 2022
- Therapeutic cancer vaccinesNature Reviews Cancer, 2021
- Roles of IFN-γ in tumor progression and regression: a reviewBiomarker Research, 2020
- Towards new horizons: characterization, classification and implications of the tumour antigenic repertoireNature Reviews Clinical Oncology, 2020
- Surgery for Cancer: A Trigger for MetastasesCancer Research, 2017
- Functionality and opposite roles of two interleukin 4 haplotypes in immune cellsGenes & Immunity, 2017
- The evolution of cancer surgery and future perspectivesNature Reviews Clinical Oncology, 2014
- Molecular and Cellular Mechanisms of Antibody Activity2013
- Rheumatology and Immunology Therapy2004